↓ Skip to main content

PLOS

Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation

Overview of attention for article published in PLOS ONE, August 2012
Altmetric Badge

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
70 Mendeley
citeulike
1 CiteULike
Title
Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation
Published in
PLOS ONE, August 2012
DOI 10.1371/journal.pone.0043580
Pubmed ID
Authors

Spencer B. Hermanson, Coby B. Carlson, Steven M. Riddle, Jing Zhao, Kurt W. Vogel, R. Jeremy Nichols, Kun Bi

Abstract

Mutations in the leucine-rich repeat kinase-2 (LRRK2) have been linked to Parkinson's disease. Recent studies show that inhibition of LRRK2 kinase activity decreased the level of phosphorylation at its own Ser910 and Ser935, indicating that these sites are prime targets for cellular readouts of LRRK2 inhibition.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 69 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 31%
Student > Ph. D. Student 15 21%
Student > Bachelor 9 13%
Student > Master 5 7%
Other 5 7%
Other 7 10%
Unknown 7 10%
Readers by discipline Count As %
Agricultural and Biological Sciences 17 24%
Biochemistry, Genetics and Molecular Biology 11 16%
Chemistry 11 16%
Medicine and Dentistry 8 11%
Neuroscience 6 9%
Other 7 10%
Unknown 10 14%